High cancer drug prices affect the care of patients and our health care system as a whole. In the U.S., the price of cancer drugs has increased five to tenfold in 15 years, from an average of $5,000-$10,000 before 2000 to more than $100,000 by 2012. This is causing harm to millions of patients and their families.
In this Houston Chronicle op-ed, Hagop Kantarjian, nonresident fellow in health policy, explains how to lower the prices of cancer drugs.
Read "Patients take action against cancer drug prices" in the March 17, 2015, edition of the Houston Chronicle.